Phase I study of single‐dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients

Belatacept is an intravenously infused selective T cell costimulation blocker approved for preventing organ rejection in renal transplant recipients aged ≥18 years. This phase I trial examined the pharmacokinetics and pharmacodynamics (percentage CD86 receptor occupancy [%CD86RO]) of a single dose o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am J Transplant
Main Authors: Moudgil, Asha, Dharnidharka, Vikas R., Feig, Daniel I., Warshaw, Barry L., Perera, Vidya, Murthy, Bindu, Roberts, Mustimbo E., Polinsky, Martin S., Ettenger, Robert B.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Brief Communications
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590112/
https://ncbi.nlm.nih.gov/pubmed/30582294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15236
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker